1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Best clinical practice guidance for conscious sedation of children undergoing dental treatment: an EAPD policy document

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Due to fear and/or behaviour management problems, some children are unable to cooperate for dental treatment using local anaesthesia and psychological support alone. Sedation is required for these patients in order for dentists to be able to deliver high quality, pain-free dental care.

          The aim of this guideline is to evaluate the efficacy and relative efficacy of conscious sedation agents and dosages for behaviour management in paediatric dentistry and to provide guidance as to which sedative agents should be used.

          Methods

          These guidelines were developed using a multi-step approach adapted from that outlined by the National Institute for Clinical Excellence (NICE (2020) Developing NICE Guidelines: the manual. https://www.nice.org.uk/process/pmg20/chapter/introduction#main-stages-of-guideline-development. Accessed 7 Oct 2020). Evidence for this guideline was provided from a pre-existing Cochrane review (Ashley et al. Cochrane Database Syst Rev 12:CD003877, 2018) supplemented by an updated search and data extraction up to May 2020.

          Results

          Studies were from 18 different countries and had recruited 4131 participants overall with an average of 70 participants per study. Ages ranged from 0 to 16 years with an average age of 5.6 years across all included studies. A wide variety of drugs or combinations of drugs ( n = 38) were used and delivered orally, intranasally, intravenously, rectally, intramuscularly, submucosally, transmucosally or by inhalation sedation. Twenty-four different outcome measures for behaviour were used. The wide range of drug combinations and outcome measures used greatly complicated description and analysis of the data.

          Conclusion

          Oral midazolam is recommended for conscious dental sedation. Midazolam delivered via other methods or nitrous oxide/oxygen sedation could be considered, but the evidence for both was very low.

          Supplementary Information

          The online version contains supplementary material available at 10.1007/s40368-021-00660-z.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: not found
          • Article: not found

          GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin.

            Extensive research has failed to clarify the mechanism of action of nitrous oxide (N2O, laughing gas), a widely used inhalational anesthetic and drug of abuse. Other general anesthetics are thought to act by one of two mechanisms-blockade of NMDA glutamate receptors or enhancement of GABAergic inhibition. Here we show that N2O, at anesthetically-relevant concentrations, inhibits both ionic currents and excitotoxic neurodegeneration mediated through NMDA receptors and, like other NMDA antagonists, produces neurotoxic side effects which can be prevented by drugs that enhance GABAergic inhibition. The favorable safety record of N2O may be explained by the low concentrations typically used and by the fact that it is usually used in combination with GABAergic anesthetics that counteract its neurotoxic potential.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Biologic effects of nitrous oxide: a mechanistic and toxicologic review.

              Nitrous oxide is the longest serving member of the anesthesiologist's pharmacologic armamentarium but remains a source of controversy because of fears over its adverse effects. Recently, the Evaluation of Nitrous oxide In a Gas Mixture for Anaesthesia (ENIGMA) trial reported that nitrous oxide use increases postoperative complications; further preclinical reports have suggested that nitrous oxide may contribute to neurocognitive dysfunction in the young and elderly. Therefore, nitrous oxide's longevity in anesthetic practice is under threat. In this article, the authors discuss the evidence for the putative toxicity of nitrous oxide, from either patient or occupational exposure, within the context of the mechanism of nitrous oxide's action. Although it would seem prudent to avoid nitrous oxide in certain vulnerable populations, current evidence in support of a more widespread prescription from clinical practice is unconvincing.
                Bookmark

                Author and article information

                Contributors
                p.ashley@ucl.ac.uk
                Journal
                Eur Arch Paediatr Dent
                Eur Arch Paediatr Dent
                European Archives of Paediatric Dentistry
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                1818-6300
                1996-9805
                28 August 2021
                28 August 2021
                2021
                : 22
                : 6
                : 989-1002
                Affiliations
                [1 ]GRID grid.83440.3b, ISNI 0000000121901201, Paediatric Dentistry, , UCL Eastman Dental Institute, ; Rockefeller Building, University St, London, WC1E 6DE UK
                [2 ]Royal National ENT and Eastman Dental Hospitals, UCLH NHS Trust, 47-49 Huntley Street, London, WC1E 6DG UK
                [3 ]GRID grid.4714.6, ISNI 0000 0004 1937 0626, Department of Dental Medicine, Division of Orthodontics and Pediatric Dentistry, , Karolinska Institutet, ; POB 4064, SE-141 04 Huddinge, Sweden
                Author information
                http://orcid.org/0000-0003-0312-5311
                Article
                660
                10.1007/s40368-021-00660-z
                8629790
                34453697
                747d163f-877e-49b1-beab-23ca25a7cfc7
                © The Author(s) 2021

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 19 July 2021
                : 12 August 2021
                Categories
                Invited Review
                Custom metadata
                © European Academy of Paediatric Dentistry 2021

                sedation,dental,paediatric,midazolam,nitrous oxide
                sedation, dental, paediatric, midazolam, nitrous oxide

                Comments

                Comment on this article